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ABSTRACT
Radiation proctocolitis is a common side effect of radiation therapy. In rare cases, chronic radiation injury can be severe enough 
to cause rectal necrosis. In this study, a case of rectal necrosis after sacral spine radiotherapy was presented. Anterior rectal 
wall necrosis and rectovaginal fistula is thought to be rare, severe and challenging rectal long-term complication of the previous 
sacral spine irradiation. Although, rectovaginal fistula which resulted in intractable rectal bleeding seems to be a rare side-effect 
of radiotherapy, physicians must not forget about this complication, as it can be fatal in patients who often have been cured of 
cancer.
CASE REPORT 
A 61-year-old woman presented to the Oncology outpatient 
department with occasional slight blood-stained stool, associated 
with mild to moderate anal pain for since 25 days. Her symptoms 
have been constant and gradually worsening in intensity. She had 
the personal history of the left breast cancer diagnosed two years 
ago, for which the patient was treated with left breast lumpectomy 
plus whole breast radiation and hormonal therapy. Sacral spine 
metastasis was detected seven months after primary diagnosis, in 
follow-up [Table/Fig-1].
The patient had undergone treatment with high-dose extended field 
Three-Dimensional Conformal Radiation Therapy (3DCRT) of the 
sacral spine with a total dose of 60 Gy (6000 rads) in 24 fractions 
[Table/Fig-2]. There was no significant adverse effect during the 
acute phase except mild acute cystitis and mild proctitis.
During the initial 18 months of three-dimensional radiation treatment 
planning apart from mild itching in her anus, she was otherwise 
symptom-free. 
She was in her usual state of health until 25 days ago when a 
slight blood-stained stool developed. The physical examination 
was unremarkable except for mild perineal dermatitis and vaginal 
discharge. So, the patient admitted for further diagnostic workup. 
The last pelvic Computed Tomography (CT) scan revealed that 
lytic lesion of sacral vertebrae involving S1, S2, and S3 vertebra, 
extending to the neural foramina of the involved vertebra [Table/Fig-1]. 
Colonoscopy on this admission revealed few rectal angioectasia 
and multiple irregular necrotic ulcers distributing circumferentially 
in 15-35 cm from the anal verge. Examination under anaesthesia 
confirmed a large anterior rectal ulcer about 9 cm from the anal verge. 
Biopsies were taken and histology revealed an ischemic colitis with 
coagulation necrosis in the area of the rectal ulcer. Serum tumour 
markers {Cancer Antigen (CA) 19-9, CA 15-3, Carcinoembryonic 
Antigen (CEA)} were within normal limits. The patient had 
undergone medical treatment with Asacol {anti-inflammatory- 
5-Aminosalicylic Acid (5-ASA) preparations}, Sucralfate (protective 
barrier and promote epithelial healing), Metronidazole (Antibiotic) 
and a Hydrocortisone (anti-inflammatory-steroid preparations) 
enema. However, the patient has continued having rectal bleeding 
and significant drop in haematocrit was occurred. At this point, the 
patient underwent surgical removal of affected rectum and distal 
sigmoid colon due to intractable bleeding. During surgery, severe 
[Table/Fig-1]: A) Spine transverse; B) coronal; and C) sagittal CT-scan simula-
tion site for targeted large lytic lesion of sacral vertebrae of 8.6×5.6×6.7 cm in size 
involving S1, S2, and S3 vertebra, extending to the neural foramina of the involved 
vertebra.
[Table/Fig-2]: 3DCRT plan of the A) sacral spine and B) dose-volume histograms. 
(Images from left to right)
adhesions between uterus and rectum and fistulisation of rectum 
to uterus with full thickness necrosis extending from recto-sigmoid 
junction to the dentate line were found. Excision of the rectum and 
sigmoid colon with anastomosis of descending colon and anus 
were performed. Rectal specimen revealed transmural necrosis 
with extensive mucosal ulceration.
Following the surgery rectal bleeding was stopped and patient 
postoperative period was uneventful and she was discharged home 
on the seventh day.
DISCUSSION 
Acute radiation proctocolitis is a common side effect of radiation 
therapy, occurring in 50-75% of patients receiving radiation to the 
pelvis [1]. Chronic radiation proctocolitis is an indolent process that 
can arise in approximately 5-15% of patients who had pelvic radiation 
therapy and typically become evident any time up to two years after 
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the cessation of therapy, although onset of clinical manifestations 
may be delayed beyond two years and in some cases have occurred 
decades later [2]. In this case, chronic radiation injury becomes 
evident after 18 months. On rare occasions, chronic radiation injury 
can be severe enough to cause rectal wall perforation or necrosis. 
In most cases, injury occurs in patients who have received at least 
4500 cGy [3]. Similarly, present patient has received 6000 cGy in her 
in their pelvic radiation course. So far, there have been few cases of 
radiation induced rectal necrosis recognised and diagnosed whom 
were almost always treated with concurrent radiosensitive agents 
with or without bevacizumab [4,5]. In contrast to these reports, our 
patient had not been given any concomitant radiosensitising agent. 
Hence, anterior rectal necrosis still remains poorly defined and is an 
underestimated problem in oncology. This abnormality is thought 
to be late severe and challenging rectal effect of the previous pelvis 
irradiation.
Risk factors for acute radiation proctocolitis include conditions 
that may limit splanchnic perfusion such as hypertension, diabetes 
mellitus, coronary artery disease, heavy smoking and restricted 
mobility of the small intestine due to adhesions [6]. Thus, diabetic 
cancer patients treated with radiation therapy have improved 
outcomes if they take metformin to control their diabetes [7]. 
Also, injury can be potentiated by concomitant administration of 
chemotherapeutic agents such as gemcitabine, 5-fluorouracil, 
doxorubicin, dactinomycin and methotrexate that act as radiation 
sensitizers [8]. The Multi-Leaf Collimators (MLC) is important tool 
used on linear accelerator that could significantly minimise damage 
to surrounding healthy tissue by reducing the out-of-field dose due 
to a reduction in scatter from the primary and secondary collimator, 
transmission through the collimator and head leakage [9].
Rectal epithelium’s capacity for regeneration could help the mucosal 
radiation injury to repair without any intervention after the cessation 
of radiation therapy [10]. 
In contrast, chronic radiation proctitis is characterised by a 
progressive occlusive vasculitis that leads to chronic ischaemia 
and fibrosis that affects all layers of the rectal wall, rather than the 
mucosa alone. These changes can lead to strictures, abscesses, 
and fistulas, which are responsible for the clinical manifestations of 
chronic radiation proctitis [11].
Although, rectal bleeding is most often the presenting symptom of 
chronic proctitis in the setting of prior radiation, similar to present 
patient, it should not be assumed that this is the sole cause. In 
fact, endoscopic findings reveal that one third of diagnoses in this 
setting were unrelated to the previous radiotherapy and significant 
neoplasia was noted in 12% [12].
Patients with more severe acute radiation proctocolitis seem to be prone 
to chronic proctocolitis. However, the lack of early complications does 
not guarantee the lack of late chronic radiation-induced injury [13].
Because clinical symptoms alone are unreliable for the diagnosis 
of radiation proctitis, endoscopic evaluation is mandatory with any 
new onset of hematochezia after prior radiation therapy [14].
CONCLUSION
Although late rectal necrosis following pelvic radiation seems to be an 
extremely rare, physicians must keep in mind about this complication, 
as it can be fatal in patients who often have been cured of cancer. 
Late rectal wall necrosis and radiation fistula should be considered in 
the differential diagnosis if the patient received pelvic radiation doses 
greater than 4500 cGy. The clinical and endoscopic evaluation of 
rectal wall necrosis is not always conclusive. However, endoscopic 
evaluation and biopsy are necessary for diagnosis, especially for 
those with history of repeated and prolonged symptoms. Surgery is 
a viable diagnostic and therapeutic option in patients with persistent 
symptoms and equivocal endoscopic findings.
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